Gentris, a global provider of pharmacogenomics and biorepository solutions, has partnered with BioFortis to integrate its Labmatrix and Qiagram software into Gentris' laboratory operations. The Labmatrix and Qiagram software will provide an advanced platform for clients to view and manage samples housed in the Gentris biorepository, while simultaneously enhancing their ability to collect, harmonize and integrate multiple data sources, including clinical, molecular, patient and biospecimen data.

Gentris has hired John Doyle as vice president of information technology to lead the implementation of BioFortis' solution. John has 25 years of experience at IBM.

BioFortis is a provider of web-based, enterprise-class, scientific intelligence solutions for clinical and translational research. Its software was created to integrate and query disparate data from multiple sources including biomarker, translational, clinical and healthcare data sets. This platform allows for the aggregation and exchange of existing and new data sets, making it accessible to multiple stakeholders. By combining Labmatrix’s ability to facilitate more efficient and effective analysis of scientific data across an organization with Gentris' biobanking and genomic biomarker services, the two companies can help pharmaceutical and biotechnology sponsors accelerate translational research and advance the application of personalized medicine to improve patient care.